Reijo Laaksonen is a cardiovascular Clinical Pharmacologist with extensive scientific training at Clinical Research Institute of Montreal, Canada and Free University of Brussels (Erasmus hospital). He has over 100 original scientific publications and numerous patents in the cardiovascular field. Reijo was Coordinator of one of the largest EU funded cardiovascular FP7 project – “Atheroremo”. Scientific manager of the 6 million euro AtheroFlux project and Steering Committee member of 6 million euro RiskyCAD project. He is also in charge of the medical operations at the Finnish Clinical Biobank, Tampere and Director of Finnish Cardiovascular Research Center Tampere.